Coming October 30: SABCS releases its session titles, and the full abstracts follow on November 23. We’ll add the program and the organizations presenting it once they’re out.

Pharmaceutical companies at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

14 pharmaceutical companies are at SABCS 2026 — 14 with a booth in the exhibit hall. 14 of them have their own page in this guide. As of Sep 27, 2026.

All 124 organizations at SABCS 2026 →

Showing 1–14 of 14 organizations
OrganizationSABCS 2026 Attendance
AstraZeneca
Cambridge, UK
Pharma
Global drugmaker whose breast cancer medicines include HER2- and TROP2-directed antibody-drug conjugates and treatments for hormone receptor-positive disease.
Booth
Exhibiting at Booth 624
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
BeOne Medicines
Basel, Switzerland
Pharma
Global oncology company developing and selling treatments for blood cancers and solid tumors, aiming for wider and more affordable access.
Booth
Exhibiting at Booth 1543
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Daiichi Sankyo
Tokyo, Japan
Pharma
Japanese drugmaker whose oncology portfolio centers on antibody-drug conjugates, including HER2- and TROP2-directed treatments used in breast cancer.
Booth
Exhibiting at Booth 343
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Eli Lilly and Company
Indianapolis, IN
Pharma
Global drugmaker whose cancer medicines include treatments for hormone receptor-positive breast cancer.
Booth
Exhibiting at Booth 324
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Genentech
South San Francisco, CA
Pharma
Roche Group biotechnology company whose breast cancer medicines include HER2-targeted antibodies and treatments for hormone receptor-positive disease.
Booth
Exhibiting at Booth 125
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Gilead Sciences
Foster City, CA
Pharma
Biopharma company whose cancer portfolio spans antibody-drug conjugates, small molecules and, through Kite, cell therapies.
Booth
Exhibiting at Booth 608
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Jazz Pharmaceuticals
Dublin, Ireland
Pharma
Global biopharma company with medicines for serious diseases, including zanidatamab, a HER2-targeted bispecific antibody studied in breast cancer.
Booth
Exhibiting at Booth 1642
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Menarini-Stemline
New York, NY
Pharma
Oncology company in the Menarini Group that markets elacestrant (Orserdu) for ESR1-mutated, ER+/HER2- advanced breast cancer.
Booth
Exhibiting at Booth 309
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Merck & Co.
Rahway, NJ
Pharma
Global drugmaker with one of the largest oncology development programs, spanning more than 30 tumor types, including immunotherapy for triple-negative breast cancer.
Booth
Exhibiting at Booth 1108
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Novartis
Basel, Switzerland
Pharma
Swiss drugmaker whose breast cancer medicines include treatments for hormone receptor-positive disease.
Booth
Exhibiting at Booth 643, 1142
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Organon
Jersey City, NJ
Pharma
Women's health drugmaker whose portfolio includes biosimilars, among them a trastuzumab biosimilar for HER2-positive breast cancer.
Booth
Exhibiting at Booth 1209
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Pfizer
New York, NY
Pharma
Global drugmaker whose breast cancer medicines include treatments for hormone receptor-positive and HER2-positive disease.
Booth
Exhibiting at Booth 1124
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Boehringer Ingelheim
Ingelheim am Rhein, Germany
Pharma
Family-owned drugmaker whose oncology pipeline targets cancer cells directly and harnesses the immune system.
Booth
Exhibiting at Booth 1551
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Pharma
Global biopharma company developing medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience.
Booth
Exhibiting at Booth 151
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from pharmaceutical companies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse SABCS 2026 by

Exhibit hall

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction